| Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc |
| Journal website http://www.gastrores.org |
Original Article
Volume 4, Number 3, June 2011, pages 107-113
Low Risk of Thromboembolic Complications After Fast-Track Abdominal Surgery With Thrombosis-Prophylaxis Only During Hospital Stay
Tables
| All patients (n = 98) | Venography (n = 17) | |
|---|---|---|
| Age (years) | 67 (19 - 90) | 71 (44 - 89) |
| Weight (kg) | 67 (35 - 124) | 66 (35 - 124) |
| Gender | ||
| Male | 40 (40.8%) | 8 (47.1%) |
| Female | 58 (59.2%) | 9 (52.9%) |
| ASA-score | ||
| ASA 1 | 6 (6.1%) | 0 |
| ASA 2 | 69 (70.4%) | 13 (76.5%) |
| ASA 3 | 23 (23.5%) | 4 (23.5%) |
| Indication for surgery | ||
| Cancer | 77 (78.6%) | 11 (64.7%) |
| Benign disease | 21 (21.4%) | 6 (35.3%) |
| Type of surgery | ||
| Right hemicolectomy | 52 (53.1%) | 10 (58.8%) |
| Left hemicolectomy + sigmoid resection | 30 (30.6%) | 2 (11.8%) |
| Subtotal colectomy | 5 (5.1%) | 0 |
| Stoma closure | 6 (6.1%) | 2 (11.8%) |
| Low anterior resection | 4 (4.1%) | 3 (17.6%) |
| Enterography | 1 (1.0%) | 0 |
| All patients (n = 98) | Venography (n = 17) | |
|---|---|---|
| Complications | 31 (31.6%) | 4 (23.5%) |
| Prolonged nausea/vomiting | 7 (7%) | 1 (5.9%) |
| Urinary tract infection | 6 (6%) | 1 (5.9%) |
| Pneumonia | 6 (6%) | 0 |
| Superficial wound infection | 5 (5%) | 1 (5.9%) |
| Intra-abdominal abscess/septicemia | 6 (6%) | 1 (5.9%) |
| Anastomotic leakage | 8 (8%) | 1 (5.9%) |
| Cardiac infarction | 1 (1%) | 0 |
| Thromboembolic complications in hospital | 0 | 0 |
| Thromboembolic events after discharge | 1 (1%) | 0 |
| Mortality | 1 (1%) | 0 |
| Hospital stay | 3 (2 - 40) | 3 (3 - 6) |
| Readmission | 15 (15.3%) | 3 (17.6%) |
| All patients (n = 98) | Venography (n = 17) | |
|---|---|---|
| Previous history of DVT (n) | - | 2 |
| Thromboembolic disposition (n) | - | 7 (41.2%) |
| AT-III deficiency | - | 1 (5.9%) |
| Protein S deficiency | - | 0 |
| Protein C deficiency | - | 0 |
| Factor V Leiden mutation | - | 1 (5.9%) |
| Cardiolipin antibodies | - | 2 (11.8%) |
| Lupus anticoagulants | - | 4 (23.5%) |
| Prothrombin mutation | - | 0 |
| Days with LMWH | ||
| 4 days or less | 49 (50%) | 13 (76.4%) |
| 5 days | 14 (14.3%) | 2 (11.8%) |
| 6 days | 14 (14.3%) | 0 |
| 7 days | 7 (7.1%) | 2 (11.8%) |
| > 7 days | 13 (13.3%) | 0 |
| DVT by venography | - | 0 |
| DVT by clinical exam day 8 | 0 | 0 |
| DVT by clinical exam day 30 | 0 | 0 |
| PE during the first 30 days | 1 | 0 |